Posted by AGORACOM-JC
at 8:01 AM on Monday, January 11th, 2021
Company has commenced providing COVID-19 testing for Air Canada’s front-line employees who interact with members of the travelling public.
The Company’s COVID testing arrangement with Air Canada is being done on an as-needed basis as Datametrex has been selected as one of the testing and travel partners of Air Canada as publicly disclosed by Air Canada in a tweet dated November 22, 2020.
Toronto, Ontario–(January 11, 2021) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”) is pleased to provide an update on its COVID-19 testing business and announce that the Company has commenced providing COVID-19 testing for Air Canada’s (“Air Canada”) front-line employees who interact with members of the travelling public. The Company’s COVID testing arrangement with Air Canada is being done on an as-needed basis as Datametrex has been selected as one of the testing and travel partners of Air Canada as publicly disclosed by Air Canada in a tweet dated November 22, 2020.
The PCR based COVID-19 testing to be arranged by the Company will be for Air Canada employees including, pilots, pilot trainees, and flight attendants.
“With many companies looking to keep employees safe and healthy and especially with flight crews requiring a negative COVID-19 test to fly, Datametrex is proud to be a solution partner with Air Canada to safely and with confidence keep its flight crews and customers alike protected. Datametrex has provided thousands of PCR based tests to companies and employees over the last seven months and believes that continued testing of the public is the gold standard to protecting everyone and containing the spread of the COVID-19 virus,” commented Marshall Gunter, Datametrex’s Chief Executive Officer.
Posted by AGORACOM-JC
at 8:27 PM on Sunday, January 10th, 2021
There is a lot we could say about American Creek Resources (AMK:TSXV) Treaty Creek Project but you might accuse of us of making it up, so we’ll let the words of 4 much smarter and wealthier people do all the talking:
Eric Sprott, Billionaire Investor and 2X Investor In American Creek Resources
“It certainly looks like they have 20 million ounces and they could easily get to 30 or 40 or 50 million ounces (of gold)” – July 24, 2020
Darren Blaney, President & CEO American Creek Resources
“Clearly, we have a massive, world-class gold system that still shows no signs of weakening to the northeast nor at depth.”
Walter Storm, CEO Tudor Gold (JV Partner) And Financier Of Osisko Gold Reaching $4.5 Billion Market Cap
“These results have proven that we have an excellent understanding of the structure, geology and mineralogy of this massive gold system.”
Ken Konkin , Tudor Gold Exploration Manager (Credited With Discovering Brucejack Mine Just South Of Treaty Creek)
“Given the success of the two deep drill holes GS19-47 and GS19-48, the Goldstorm System shows no signs of weakening to the northeast and several more drill holes will be needed to find the length and depth of this huge gold system.“
Posted by AGORACOM-JC
at 8:22 PM on Sunday, January 10th, 2021
Most of us know drones as cool toys flying around the neighbourhood, or perhaps even as simple commercial applications for things like real estate videos.
But the fact of the matter is that drone usage is about to go parabolic with huge corporations now testing ways to:
Deliver vaccines with drones.
Use drones to provide Internet connections in remote locations.
Use drones to collect data.
Use drones to detect infectious conditions from a distance of 190 feet.
…… And there’s even a start-up that’s using drones to deliver tacos to your door.
In short, the drone industry is booming in ways people can’t imagine because the industry is shifting from the drones (hardware) to data … and one company is already ahead of the shift … DraganFly (DFLY: CSE) (DFLYF:OTCQB) (3U8:FSE)
DraganFly is an award-winning drone manufacturer and technology developer that is actually delivering some pretty incredible achievements, milestones and even history:
Established in 1998 DFLY is considered the oldest commercial drone company in the world
Built the first drone that saved a life
Boasts the first drone to be inducted into the Smithsonian National Air & Space Museum
Shooting down “smuggler” drone carrying 28lbs of heroin
Developing Vaccine Drone Delivery Payload System (it’s way more complicated than just transporting vaccines)
And last but not least was the issuance of a delivery drone patent – which sounds like no big deal until you understand how it is a GAME CHANGER for the entire drone delivery market.
If you believe in the massive parabolic growth in the use of drones for almost everything we do in this world, or are just learning, then watch / listen to this powerful interview with Draganfly CEO and Chairman, Cameron Chell
Posted by AGORACOM-JC
at 7:35 AM on Friday, January 8th, 2021
Company Continues its Track Record of Successful “Bubble” Implementations with bdG Sports
Company has been selected by bdG Sports to provide its venue management platform to the Big West Conference Men’s and Women’s Basketball Championships being held March 9-13, 2021 at the Mandalay Bay Events Center in Las Vegas.
A total of 19 men’s and women’s NCAA basketball teams will compete in the Big West Conference Finals for a chance to enter the NCAA 2020-2021 “March Madness” Tournament in Las Vegas.
Loop’s selection to provide its venue management platform at the Big West Conference Championships follows the successful deployment of Loop’s venue bubble solution at two previous NCAA basketball tournaments, the Gulf Coast Showcase and the Vegas Main Event.
VANCOUVER, British Columbia, Jan. 08, 2021 — Loop Insights Inc. (MTRX:TSXV OTCQB:RACMF) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement, and automated venue tracing to the brick and mortar space, is pleased to announce the Company has been selected by bdG Sports to provide its venue management platform to the Big West Conference Men’s and Women’s Basketball Championships being held March 9-13, 2021 at the Mandalay Bay Events Center in Las Vegas.
A total of 19 men’s and women’s NCAA basketball teams will compete in the Big West Conference Finals for a chance to enter the NCAA 2020-2021 “March Madness” Tournament in Las Vegas. Loop’s selection to provide its venue management platform at the Big West Conference Championships follows the successful deployment of Loop’s venue bubble solution at two previous NCAA basketball tournaments, the Gulf Coast Showcase and the Vegas Main Event.
Posted by AGORACOM-JC
at 7:55 AM on Thursday, January 7th, 2021
When a small cap company enters into a developer and supply agreement with a technology leader in its space AND can’t name the company, that is typically a very good thing.
Understanding the world of Photonics isn’t the easiest thing small cap investors have had to understand. In fact, it may be the very hardest thing they’ve ever had to understand. However, given the fact we are the very reason current photonics devices aren’t living up to snuff trying to keep up with our surfing, streaming, binging and zooming – you start to see why understanding photonics and POET Technologies could open up investors to a whole new world.
Before watching this video, here is some important background information.
Photonic devices create, detect and manipulate light. Laser generated light is fundamental to sensing, computing, data and telecommunications, which require the fastest transfer of data possible.
This is where POET comes in.
Why? All the surfing, streaming, binging and zooming we do requires 2 things to happen:
1. Massive data centres filled with tens of thousands of servers.
2. Speed … and we mean lighting speed that requires lasers to transfer all that data fast enough for you not to complain about 2 second latency when searching for weight-loss programs for your New Year’s resolution (We see you).
Examples of the the biggest trends sucking up all that power and speed in computing today:
Cloud Computing
Artificial Intelligence
5G and Edge
HERE IS THE PROBLEM
Making photonics devices that are reliable is expensive in terms of both capital and labor. Unlike almost every electronic device or component on this planet that has seen their costs drop dramatically over time, photonics cost declines have not kept up with Moore’s Law, with most photonics devices built one at a time. (NOT A TYPO).
The Result? Integration of components at wafer-scale has not been fully implemented even by the largest companies working for the past 20 years ….. UNTIL NOW
POET has developed a unique, disruptive and differentiating new entry into photonics markets – The POET Optical Interposer™ Platform. Don’t worry if that sounds like a mouthful. All you have to know is that it
Enables lower cost
Delivers higher performance
Across a wide range of applications like those mentioned above
Today’s press release announcing its entry into the “Artificial Intelligence Market with Technology Leader in Photonic Computing” serves as great 3rd party validation that POET Technologies can open up the AI market for its Optical Interposer Platform.
Watch this great interview with:
Suresh Venkatesan, Chairman and CEO
Vivek Rajgarhia, President & General Manager
Thomas Mika, Executive Vice President and Chief Financial Officer
Posted by AGORACOM-JC
at 11:11 AM on Tuesday, January 5th, 2021
Announced two investments, for a total of $530,000 in Electric Metals (USA) Ltd. a multi-commodity US-based resource company focused on their 100% owned Corcoran Canyon Silver Project in Nevada and Emily Manganese Project in Minnesota.
In the first private placement, The Company has acquired 1,000,000 shares (the “Shares”) at a price of $0.20 per Share in EML.
In the second private placement, The Company has acquired 1,000,000 Subscription Receipts at a price of $0.33 per Sub Receipts. Each Sub Receipts will entitle ThreeD to receive one (1) common share of EML (a “Common Share”) and one-half (1/2) of one Common Share purchase warrant (each whole warrant, a “Warrant”), with each whole warrant exercisable at $0.60 per Warrant.
The Warrants will expire two (2) years from the date of issuance.
Sheldon Inwentash has also agreed to come on as Chairman of the Board of Directors to NBS, which will take effect upon the closing of the proposed transaction with NBS.
TORONTO, Jan. 05, 2021 — ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK) (OTCQB:IDKFF) a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, is pleased to announce two investments, for a total of $530,000 in Electric Metals (USA) Ltd. (“EML ”), a multi-commodity US-based resource company focused on their 100% owned Corcoran Canyon Silver Project in Nevada and Emily Manganese Project in Minnesota.
In the first private placement, The Company has acquired 1,000,000 shares (the “Shares”) at a price of $0.20 per Share in EML.
In the second private placement, The Company has acquired 1,000,000 Subscription Receipts (the “Sub Receipts”) at a price of $0.33 per Sub Receipts. Each Sub Receipts will entitle ThreeD to receive one (1) common share of EML (a “Common Share”) and one-half (1/2) of one Common Share purchase warrant (each whole warrant, a “Warrant”), with each whole warrant exercisable at $0.60 per Warrant. The Warrants will expire two (2) years from the date of issuance.
EML signed a definitive scheme implementation agreement, effective 31st December 2020, with NBS Capital Inc. (“NBS”) (TSXV: NBS.P), as announced yesterday by NBS. Pursuant to this Agreement, NBS will acquire all of the shares of EML via share exchange for an equivalent number of NBS shares, which will result in EML becoming a wholly owned subsidiary of NBS. NBS will change its name change to Nevada Silver Corporation on closing of the proposed transaction, reflecting the focus of EML on its principal Nevada silver asset.
Sheldon Inwentash has also agreed to come on as Chairman of the Board of Directors to NBS, which will take effect upon the closing of the proposed transaction with NBS.
Sheldon Inwentash, Chairman and CEO of ThreeD Capital stated “ThreeD Capital prides itself on discovering great companies before they become known to the general investment community, and EML is no exception. With 100% ownership of a US-based primary silver-gold asset with existing resources and significant upside potential, I am confident EML will deliver exceptional value to IDK shareholders.”
Gary Lewis, Director and CEO of EML commented, “We are delighted to welcome ThreeD Capital onto the EML register and Mr. Sheldon Inwentash as our incoming Chairman at such a pivotal time in the company’s development. EML has built a strong asset base and technical capability which, when coupled with the reputation, rolodex and investment nous of Mr. Inwentash, will make for a very compelling combination.”
EML is an unlisted public company incorporated under the laws of New South Wales, Australia. It is a U.S.-based resource company, with its material asset being the 100-per-cent-owned Corcoran Canyon silver project in Nevada. EML also holds a high-grade manganese project in Minnesota, United States.
About ThreeD Capital Inc.
ThreeD is a publicly-traded Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors. ThreeD’s investment strategy is to invest in multiple private and public companies across a variety of sectors globally. ThreeD seeks to invest in early stage, promising companies where it may be the lead investor and can additionally provide investees with advisory services and access to the Company’s ecosystem.
For further information: Gerry Feldman, CPA, CA Chief Financial Officer and Corporate Secretary [email protected] Phone: 416-941-8900 ext 106
The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.
Forward-Looking Statements
This news release contains certain forward-looking statements and forward-looking information (collectively referred to herein as “forward-looking statements”) within the meaning of Canadian securities laws including, without limitation, statements with respect to the future investments by the Company. All statements other than statements of historical fact are forward-looking statements. Undue reliance should not be placed on forward-looking statements, which are inherently uncertain, are based on estimates and assumptions, and are subject to known and unknown risks and uncertainties (both general and specific) that contribute to the possibility that the future events or circumstances contemplated by the forward-looking statements will not occur. Although the Company believes that the expectations reflected in the forward looking statements contained in this press release, and the assumptions on which such forward-looking statements are made, are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking statements included in this document, as there can be no assurance that the plans, intentions or expectations upon which the forward-looking statements are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which may cause the Company’s actual performance and results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof and the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, except as required by applicable law. The forward-looking statements contained herein are expressly qualified by this cautionary statement.
Posted by AGORACOM-JC
at 1:06 PM on Thursday, December 31st, 2020
Famed Canadian Investor Sheldon Inwentash Founder, Chairman and CEO ThreeD Capital praises Loop Insights. Inwentash is extremely impressed with the company’s technology and goes on to say that Loop Insights CEO Rob Anson is the hardest working small cap CEO he knows.
Posted by AGORACOM-JC
at 11:48 AM on Wednesday, December 23rd, 2020
Announced a $750,000 order for its continuous emissions business which includes BioCloudTM units and a separate initial order from one of Ontario’s largest Electricity Generators
The continuous emissions and BioCloud revenues are anticipated to be recorded in Q1 2021
TORONTO, ON / December 23, 2020 / Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol” or “Company“), a leader in smart buildings and cities through IoT, Cloud and SaaS technology, is pleased to announce a $750,000 order for its continuous emissions business which includes BioCloudTM units and a separate initial order from one of Ontario’s largest Electricity Generators. The continuous emissions and BioCloud revenues are anticipated to be recorded in Q1 2021.
“We are very pleased to receive a significant order in our core business with a US manufacturing customer which also includes 2 BioCloud units as part of a package sale,” says Paul Ghezzi, CEO of Kontrol. “Our corporate strategy is to quote BioCloud units as part of all new sales opportunities from our core business. In addition, we are pleased that one of Ontario’s largest Electricity Generators has ordered an initial 2 units of BioCloud. Both customers have additional scale potential with numerous facilities. Our recent product launch and technology walk-through in December was a success and has initiated accelerating interest in how BioCloud can help create safer spaces.”
Distribution Orders
To date the Company has received 40 initial distribution orders for delivery in January from its existing distribution network. The Company has entered into 6 distribution agreements (1 exclusive and 5 non-exclusive) and is in negotiations for various potential additional non-exclusive distributions agreements. Distribution is a key part of our go to market strategy that can allow the Company to scale quickly.
“In a short period of time since the official launch of BioCloud in December we have received strong interest and numerous distribution requests,” says Gary Saunders, VP Kontrol. “We envision many more agreements across the globe as we focus on growing the BioCloud business.”
As the Company continues to build its distribution business, we anticipate that distributors will be required to maintain a minimum of 250-unit sales per annum to retain non-exclusivity and distributor pricing. The Company’s internal goal is to have 30 regional distributors established by the end of Q1 2021.
Customer Pilots
The Company plans to begin numerous pilots with both existing customers of Kontrol and new potential customers. The purpose of the pilots is to provide potential customers with various specific application use cases across their facilities. The types of pilot customers will include the sectors of commercial real-estate, grocery stores, franchised restaurants, educational facilities and other. Subject to pilot customer approval Kontrol may announce customer pilots or may operate them under non-disclosure agreement.
Recurring Revenue
The BioCloud unit operates with a proprietary detection chamber. The retail price for the detection chamber consumable will range from $400 to $500 and the recommended replacement is three times per year or whenever the detection chamber comes into contact with SARS-CoV-2. Customers that purchase multiple units will receive volume discounts for the detection chamber.
Re-Agent Supply Chain
The detection chamber includes a specific re-agent system. To date the Company has been sourcing its re-agents from the United States. The Company has initiated discussions and testing to source its re-agents from Canadian based sources. By doing so it is seeking to add more of its supply chain in Canada but also reduce the costs of the detection chamber. Further updates will be provided following additional testing.
Essential Service
Kontrol and its manufacturing supply chain operate as an Essential Service provider and do not anticipate being impacted by applicable COVID-19 shutdowns.
About Kontrol BioCloudTM
BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, offices, retirement homes, hospitals, mass transportation and others.
Additional information about Kontrol BioCloud can be found on its website at www.kontrolbiocloud.com
BioCloud is an air quality technology and not a medical device. The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus). Safe Space Technology is a Kontrol Trademark.
About Kontrol Energy
Kontrol Energy Corp., a Canadian public company, is a leader in smart buildings and cities through IoT, Cloud and SaaS technology. Kontrol Energy provides a combination of software, hardware, and service solutions to its customers to improve energy management, air quality and continuous emission monitoring.
Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at www.sedar.com
For further information, contact:
Paul Ghezzi, Chief Executive Officer [email protected] or [email protected] Kontrol Energy Corp. 180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8 Tel: 905.766.0400, Toll free: 1.844.566.8123
Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.
Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.
However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company’s product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. In particular, successful development and commercialization of the Kontrol BioCloud Analyzer are subject to the risk that the Kontrol BioCloud Analyzer may not prove to be successful in detecting the virus that causes COVID-19 effectively or at all, uncertainty of timing or availability of any regulatory approvals and Kontrol’s lack of track record in developing products for medical applications.
Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date. Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.
Posted by AGORACOM-JC
at 6:00 PM on Tuesday, December 22nd, 2020
Valeo Pharma is already a successful, revenue generating, small cap Canadian pharmaceutical company that acquires the Canadian rights to commercialized drugs in other parts of the world that don’t have Canada on their radar as a target market.
This “in-license” business model is ingenious because it means ZERO developmental or clinical risk, which is the downfall of most small cap pharma companies.
This model has resulted in the following success:
$5.3M in revenues in the first 9 months of 2020 (ending July 31, 2020)
9 products currently in the market with an annual estimated peak sales of $40M/year
7 products in the pipeline with an annual estimated peak sales of $45M/year
In fact, capital markets confidence is so high that Valeo secured $8.6M in financing in the last half of the year with:
$6.9M Bought Deal financing at $1.20/shares
A $1.7M Oversubscribed debenture (non-convertible)
If that was all Valeo had, most investors would be happy to sit back and watch the Company grow.
But then came Redesca. We are going to save you the science and tell you that Redesca belongs to a class of anticoagulant medications (blood thinners) called LMWH. The size of the Canadian LMWH market is over $200M per year and Valeo believes they can capture 15-30% of this market. If you’re doing back of napkin math, that equates to $30,000,000 – $60,000,000 per year in revenues.
But how does a new product capture that much market share? Glad you asked because we asked CEO Steve Saviuk the same question. Competition is tough in all markets and they don’t let someone take 15-30% market share without one hell of a fight. Saviuk agreed and gave the following 3 reasons:
1. Redesca has an 8-year international track record of safety and efficacy. It is already well known
2. Redesca is flat out cheaper, which is music to the ears of Provincial Health Ministries whose budgets have been stretched to the max this year no thanks to COVID-19.
Vaelo is so confident that it stated “This is great news for the Canadian healthcare system …. and is expected to help provide significant savings to provincial healthcare systems.”
Well there you have it. Valeo is a great story. Watch the video.
HOLD ON. THERE’S MORE … A LOT MORE
In addition to being used primarily for treating and preventing deep vein thrombosis and pulmonary embolism, LMWH are also now increasingly used as a first line of defense tool in the fight against Covid-19. The World Health Organization’s (“WHO”) issued guidance regarding the prophylaxis use of LMWH to help prevent complications in the clinical management of severe acute respiratory infections when COVID-19 infection is suspected.
The Canadian market for LMWH was already at a healthy $200M + per year when Valeo started down the Redesca path 4 years ago. Now it gets the added kicker of Redesca being a first line of defense to fight COVID-19.
Now you have it. That’s the Valeo story as it applies to Redesca. There is a whole lot more to the story given their pipeline of products but we couldn’t cover it all in this great interview with CEO Steve Saviuk.
If you love revenue generating, growing and blue sky potential small cap companies, then this Valeo interview is a must watch.